• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cell kinetics and hormonal features in relation to pathological stage in breast cancer.

作者信息

Amadori D, Bonaguri C, Nanni O, Gentilini P, Lundi N, Zoli W, Riccobon A, Vio A, Magni E, Saragoni A

机构信息

Oncology Department, Morgagni-Pierantoni Hospital, U.S.L. 38, Forli, Italy.

出版信息

Breast Cancer Res Treat. 1991 Mar;18(1):19-25. doi: 10.1007/BF01975439.

DOI:10.1007/BF01975439
PMID:1854976
Abstract

Proliferative activity (expressed as 3H-thymidine labeling index, 3H-TdR LI) was evaluated on a series of 281 primary tumors recruited in two years in 6 different institutions from central Italy. 3H-TdR LI proved to be low in intraductal, or well and moderately differentiated, or hormone receptor positive tumors. Conversely, no relation was observed between 3H-TdR LI and menopause, tumor size, or lymph node involvement. An inverse relation was observed between 3H-TdR LI and hormone receptor content. Specific patterns of 3H-TdR LI value and ER content association were observed as a function of menopause, lymph nodal status, and degree of lymph nodal involvement.

摘要

相似文献

1
Cell kinetics and hormonal features in relation to pathological stage in breast cancer.
Breast Cancer Res Treat. 1991 Mar;18(1):19-25. doi: 10.1007/BF01975439.
2
3H-thymidine-labeling index as a prognostic indicator in node-positive breast cancer.3H-胸腺嘧啶核苷标记指数作为淋巴结阳性乳腺癌的预后指标
J Clin Oncol. 1990 Aug;8(8):1321-6. doi: 10.1200/JCO.1990.8.8.1321.
3
Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapy.细胞动力学作为辅助激素治疗的淋巴结阳性乳腺癌的预测因素
J Clin Oncol. 1993 Jun;11(6):1150-5. doi: 10.1200/JCO.1993.11.6.1150.
4
Tumor-proliferative activity, progesterone receptor status, estrogen receptor level, and clinical outcome of estrogen receptor-positive advanced breast cancer.雌激素受体阳性晚期乳腺癌的肿瘤增殖活性、孕激素受体状态、雌激素受体水平及临床结局
Cancer Res. 1990 May 15;50(10):2958-62.
5
Biological correlation between HER-2/neu and proliferative activity in human breast cancer.人乳腺癌中HER-2/neu与增殖活性之间的生物学关联。
Anticancer Res. 1991 Jul-Aug;11(4):1395-400.
6
Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer.
Breast Cancer Res Treat. 1981;1(3):253-62. doi: 10.1007/BF01806265.
7
Proliferative activity of primary breast cancer and of synchronous lymph node metastases evaluated by [3H]-thymidine labelling index.通过[3H] - 胸腺嘧啶核苷标记指数评估原发性乳腺癌及同步发生的淋巴结转移灶的增殖活性。
Cell Tissue Kinet. 1990 Sep;23(5):401-8. doi: 10.1111/j.1365-2184.1990.tb01133.x.
8
Estrogen receptor heterogeneity and the relationship between estrogen receptor and the tritiated thymidine labeling index in human breast cancer.雌激素受体异质性以及人乳腺癌中雌激素受体与氚标记胸腺嘧啶核苷标记指数之间的关系。
Oncology. 1982;39(4):197-200. doi: 10.1159/000225636.
9
Relevance of cell kinetics to hormonal response of receptor-positive advanced breast cancer.
Breast Cancer Res Treat. 1988 Apr;11(1):31-6. doi: 10.1007/BF01807555.
10
Changes in cell kinetics induced by primary chemotherapy in breast cancer.原发性化疗对乳腺癌细胞动力学的影响。
Int J Cancer. 1991 Feb 1;47(3):380-3. doi: 10.1002/ijc.2910470312.

引用本文的文献

1
Establishment and characterization of a new cell line from primary human breast carcinoma.
Breast Cancer Res Treat. 1993 Dec;28(3):251-60. doi: 10.1007/BF00666586.
2
In vitro activity of taxol and taxotere in comparison with doxorubicin and cisplatin on primary cell cultures of human breast cancers.
Breast Cancer Res Treat. 1995 Apr;34(1):63-9. doi: 10.1007/BF00666492.

本文引用的文献

1
Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.乳腺癌的组织学分级与预后;对1409例病例的研究,其中359例已随访15年。
Br J Cancer. 1957 Sep;11(3):359-77. doi: 10.1038/bjc.1957.43.
2
Cell proliferation and its relationship to clinical features and relapse in breast cancers.
Cancer. 1981 Aug 15;48(4):974-9. doi: 10.1002/1097-0142(19810815)48:4<974::aid-cncr2820480420>3.0.co;2-#.
3
The long-term prognostic significance of the thymidine labelling index in breast cancer.乳腺癌中胸苷标记指数的长期预后意义。
Int J Cancer. 1984 Apr 15;33(4):441-5. doi: 10.1002/ijc.2910330404.
4
Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. Workshop, held on 16-17 March, 1979, in the Netherlands Cancer Institute.人类乳腺癌激素受体评估标准的修订;1979年3月16 - 17日于荷兰癌症研究所召开的第二届欧洲癌症研究与治疗组织研讨会报告
Eur J Cancer (1965). 1980 Nov;16(11):1513-5. doi: 10.1016/0014-2964(80)90064-x.
5
Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up.原发性乳腺癌患者肿瘤组织中的无病生存期和雌激素受体活性:长期随访后的分析
Breast Cancer Res Treat. 1985;6(2):123-30. doi: 10.1007/BF02235743.
6
The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women. Clinical correlation on 547 patients.雌激素和孕激素受体浓度对女性乳腺癌临床行为的预测价值。对547例患者的临床相关性研究。
Cancer. 1986 Mar 15;57(6):1171-80. doi: 10.1002/1097-0142(19860315)57:6<1171::aid-cncr2820570618>3.0.co;2-x.
7
Breast carcinoma cell kinetics, morphology, stage, and host characteristics. A thymidine labeling study.
Lab Invest. 1986 Jan;54(1):41-51.
8
Role of steroid hormone receptors as prognostic factors in primary breast cancer.类固醇激素受体作为原发性乳腺癌预后因素的作用。
NCI Monogr. 1986(1):19-23.
9
Prognostic factors for recurrence and survival in human breast cancer.人类乳腺癌复发和生存的预后因素。
Breast Cancer Res Treat. 1987 Oct;10(1):5-9. doi: 10.1007/BF01806129.
10
The DNA labelling index: a prognostic factor in node-negative breast cancer.
Breast Cancer Res Treat. 1987;9(3):207-11. doi: 10.1007/BF01806381.